-
Treatment and outcomes for patients with relapsed or refractory diffuse large B-cell lymphoma: a contemporary, nationwide, population-based study in the Netherlands
Pennings, E. R. A., Durmaz, M. J., Visser, O., Posthuma, E. F. M., Issa, D. E., Chamuleau, M. E. D., Lugtenburg, P. J., Kersten, M. J. & Dinmohamed, A. G., 1 Dec 2024, In: Blood Cancer Journal. 14, 1, 3.Research output: Contribution to journal › Comment/Letter to the editor › Academic
-
Population-Based External Validation of the EASIX Scores to Predict CAR T-Cell-Related Toxicities
de Boer, J. W., Keijzer, K., Pennings, E. R. A., van Doesum, J. A., Spanjaart, A. M., Jak, M., Mutsaers, P. G. N. J., van Dorp, S., Vermaat, J. S. P. & on behalf of the Dutch CAR-T Tumorboard Consortium, 1 Nov 2023, In: Cancers. 15, 22, 5443.Research output: Contribution to journal › Article › Academic › peer-review
-
The Dutch CAR-T Tumorboard Experience: Population-Based Real-World Data on Patients with Relapsed or Refractory Large B-Cell Lymphoma Referred for CD19-Directed CAR T-Cell Therapy in The Netherlands
on behalf of the Dutch CAR-T Tumorboard Consortium, 1 Sept 2023, In: Cancers. 15, 17, 4334.Research output: Contribution to journal › Article › Academic › peer-review
- All publications
